Skip to main content
SGHT logo

Sight Sciences, Inc.

SGHTNASDAQHealthcareMedical Devices

$8.99Today:- (-)1Y +74.47%

As of Oct 23, 2026 close

Market cap
$490.01M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.38$9.71
Volume (live)
-
Avg. volume (3M)
313.32K

Sight Sciences (SGHT) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Sight Sciences used $29.69M of cash in operating activities and spent $224.00K on capital expenditures. That left free cash flow of −$29.92M.

Sight Sciences Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Sight Sciences, Inc. (SGHT) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-38.43-51.51-55.55-86.24-62.96-34.69-25.87-14.29
Depreciation & Amortization0.490.710.610.710.630.550.300.06
Deferred Income Tax0.000.000.000.007.760.000.000.00
Stock Based Compensation13.0517.0814.5812.965.080.500.120.05
Change in Working Capital-6.409.00-9.13-5.70-4.330.78-0.34-0.36
Change in Accounts Receivable0.913.550.66-6.84-3.69-1.48-2.32-1.42
Change in Inventory-1.441.63-2.16-3.25-1.31-1.72-1.80-0.18
Change in Accounts Payable-0.350.34-0.88-0.691.170.450.171.00
Change in Other Working Capital1.441.400.671.09-2.753.533.610.24
Other Operating Activities1.441.402.302.309.03-0.260.800.06
Net Cash from Operating Activities-29.69-22.35-47.18-75.97-52.54-32.17-25.00-14.48
Investing Activities
Capital Expenditures-0.22-0.39-0.79-0.97-0.81-0.95-0.67-0.57
Net Cash from Investing Activities-0.22-0.39-0.79-0.97-0.81-0.95-0.67-0.57
Financing Activities
Debt Repayment0.00-35.380.000.000.0020.4814.000.00
Common Stock Issued1.851.071.331.25257.040.030.0012.20
Common Stock Repurchased0.00-0.02-0.220.000.000.000.000.00
Other Financing Activities-0.06-0.26-0.220.00-4.51-0.5128.6612.20
Net Cash from Financing Activities1.794.961.101.25252.5373.4042.6612.20
Summary
Net Change in Cash-28.13-17.77-46.87-75.69199.1840.2717.00-2.84
Cash at Beginning of Period120.36138.13185.00260.6961.5121.244.247.08
Cash at End of Period92.23120.36138.13185.00260.6961.5121.244.24
Free Cash Flow-29.92-22.74-47.98-76.94-53.35-33.13-25.67-15.05
Supplemental Disclosures
Interest Paid-4.264.273.253.111.29--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sight Sciences Cash Flow

What is Sight Sciences's free cash flow?

Sight Sciences had negative free cash flow of $29.92M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$29.69M minus $224.00K of capital expenditures.

How much does Sight Sciences spend on capital expenditures?

Sight Sciences spent $224.00K on capital expenditures in fiscal 2025, compared with $385.00K a year earlier.

Does Sight Sciences pay dividends or buy back shares?

Sight Sciences's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition